Nov. 20, 2024 — Scientists have identified human antibodies capable of targeting the proteins responsible for severe malaria, potentially paving the way for new vaccines or treatments.
That has presented a "clear and present danger" that strains of P falciparum and other malaria parasites may emerge that are resistant to all current drugs. "These results are definitely good news ...
Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...
Approximately half of all respondents reported that their facility uses tall man lettering for similar drug names that appear on pharmacy computer drug selection screens, computer-generated ...